Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma – A pilot study.

MLA

Borgatti, Antonella, et al. “Evaluation of 18-F-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) as a Staging and Monitoring Tool for Dogs with Stage-2 Splenic Hemangiosarcoma – A Pilot Study.” PLoS ONE, vol. 12, no. 2, Feb. 2017, pp. 1–13. EBSCOhost, https://doi.org/10.1371/journal.pone.0172651.

APA

Borgatti, A., Winter, A. L., Stuebner, K., Scott, R., Ober, C. P., Anderson, K. L., Feeney, D. A., Vallera, D. A., Koopmeiners, J. S., Modiano, J. F., & Froelich, J. (2017). Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma – A pilot study. PLoS ONE, 12(2), 1–13. https://doi.org/10.1371/journal.pone.0172651

Chicago

Borgatti, Antonella, Amber L. Winter, Kathleen Stuebner, Ruth Scott, Christopher P. Ober, Kari L. Anderson, Daniel A. Feeney, et al. 2017. “Evaluation of 18-F-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) as a Staging and Monitoring Tool for Dogs with Stage-2 Splenic Hemangiosarcoma – A Pilot Study.” PLoS ONE 12 (2): 1–13. doi:10.1371/journal.pone.0172651.